Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
SAI Life Sciences Ltd. ( (IN:SAILIFE) ) just unveiled an update.
Sai Life Sciences Ltd. has announced the scheduling of its 26th Annual General Meeting (AGM) on September 11, 2025, to be held virtually in compliance with regulatory guidelines. This meeting will include the presentation of the annual report for the financial year 2024-25, reflecting the company’s ongoing commitment to transparency and regulatory adherence, which is crucial for maintaining stakeholder trust and industry credibility.
More about SAI Life Sciences Ltd.
Sai Life Sciences Ltd. operates in the pharmaceutical industry, focusing on providing contract research, development, and manufacturing services to global pharmaceutical and biotechnology companies. The company is known for its comprehensive solutions across the drug discovery and development spectrum, catering to a diverse range of therapeutic areas.
Average Trading Volume: 366,016
Technical Sentiment Signal: Strong Buy
Current Market Cap: 165.6B INR
Find detailed analytics on SAILIFE stock on TipRanks’ Stock Analysis page.